Q80X76
Gene name |
Serpina3f |
Protein name |
Serine protease inhibitor A3F |
Names |
Serpin A3F |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:238393 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q80X76
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q80X76-F1 | Predicted | AlphaFoldDB |
51 variants for Q80X76
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs249721786 | 4 | V>I | No | EVA | |
| rs29138924 | 10 | G>V | No | EVA | |
| rs3403006943 | 11 | C>F | No | EVA | |
| rs3403241020 | 11 | C>S | No | EVA | |
| rs214061443 | 17 | G>E | No | EVA | |
| rs3389216816 | 17 | G>R | No | EVA | |
| rs3389271772 | 28 | N>S | No | EVA | |
| rs236759664 | 29 | I>V | No | EVA | |
| rs3413093340 | 32 | V>G | No | EVA | |
| rs3403674063 | 38 | A>V | No | EVA | |
| rs262800569 | 50 | K>R | No | EVA | |
| rs587106051 | 51 | E>K | No | EVA | |
| rs224642426 | 69 | C>S | No | EVA | |
| rs29491238 | 73 | A>T | No | EVA | |
| rs580685307 | 92 | K>R | No | EVA | |
| rs3403584919 | 98 | T>N | No | EVA | |
| rs582925938 | 101 | P>L | No | EVA | |
| rs581620618 | 119 | N>D | No | EVA | |
| rs29154535 | 124 | S>N | No | EVA | |
| rs3403654390 | 131 | I>V | No | EVA | |
| rs3389271692 | 142 | K>E | No | EVA | |
| rs3389231489 | 161 | P>H | No | EVA | |
| rs3403674061 | 165 | T>R | No | EVA | |
| rs387326142 | 175 | H>Q | No | EVA | |
| rs49422322 | 200 | Y>* | No | EVA | |
| rs230213466 | 221 | L>V | No | EVA | |
| rs580072326 | 243 | R>Q | No | EVA | |
| rs582621852 | 257 | T>R | No | EVA | |
| rs222821869 | 271 | K>R | No | EVA | |
| rs3389266304 | 279 | L>* | No | EVA | |
| rs33106418 | 286 | N>K | No | EVA | |
| rs3389266366 | 288 | K>M | No | EVA | |
| rs585724254 | 289 | D>N | No | EVA | |
| rs33104349 | 297 | N>D | No | EVA | |
| rs3389231505 | 330 | D>E | No | EVA | |
| rs3389266318 | 341 | R>K | No | EVA | |
| rs3389249914 | 346 | V>I | No | EVA | |
| rs3389266346 | 356 | T>A | No | EVA | |
| rs234773148 | 362 | A>V | No | EVA | |
| rs3389258833 | 363 | G>S | No | EVA | |
| rs3389255857 | 375 | V>L | No | EVA | |
| rs1133153174 | 376 | I>M | No | EVA | |
| rs1133958055 | 378 | S>F | No | EVA | |
| rs1132433080 | 379 | M>L | No | EVA | |
| rs33108777 | 384 | D>N | No | EVA | |
| rs29194568 | 406 | S>T | No | EVA | |
| rs237402497 | 417 | V>G | No | EVA | |
| rs3389231518 | 424 | V>M | No | EVA | |
| rs3389231522 | 429 | P>L | No | EVA | |
| rs215219207 | 443 | T>P | No | EVA | |
| rs387538769 | 444 | R>T | No | EVA |
No associated diseases with Q80X76
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| serine-type endopeptidase inhibitor activity | Binds to and stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of endopeptidase activity | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| response to bacterium | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. |
| response to cytokine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
| response to peptide hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. |
37 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q9N2I2 | SERPINA5 | Plasma serine protease inhibitor | Bos taurus (Bovine) | PR |
| P41361 | SERPINC1 | Antithrombin-III | Bos taurus (Bovine) | PR |
| Q1JPB0 | SERPINB1 | Leukocyte elastase inhibitor | Bos taurus (Bovine) | PR |
| P13909 | SERPINE1 | Plasminogen activator inhibitor 1 | Bos taurus (Bovine) | PR |
| Q9TTE1 | SERPINA3-1 | Serpin A3-1 | Bos taurus (Bovine) | PR |
| A2I7N1 | SERPINA3-5 | Serpin A3-5 | Bos taurus (Bovine) | PR |
| A6QPQ2 | SERPINA3-8 | Serpin A3-8 | Bos taurus (Bovine) | PR |
| A2I7N2 | SERPINA3-6 | Serpin A3-6 | Bos taurus (Bovine) | PR |
| A2I7M9 | SERPINA3-2 | Serpin A3-2 | Bos taurus (Bovine) | PR |
| O73790 | SERPINB10 | Heterochromatin-associated protein MENT | Gallus gallus (Chicken) | PR |
| P05121 | SERPINE1 | Plasminogen activator inhibitor 1 | Homo sapiens (Human) | PR |
| Q9UK55 | SERPINA10 | Protein Z-dependent protease inhibitor | Homo sapiens (Human) | PR |
| P05155 | SERPING1 | Plasma protease C1 inhibitor | Homo sapiens (Human) | PR |
| P08697 | SERPINF2 | Alpha-2-antiplasmin | Homo sapiens (Human) | PR |
| Q86WD7 | SERPINA9 | Serpin A9 | Homo sapiens (Human) | PR |
| P01008 | SERPINC1 | Antithrombin-III | Homo sapiens (Human) | PR |
| P07093 | SERPINE2 | Glia-derived nexin | Homo sapiens (Human) | PR |
| Q96P15 | SERPINB11 | Serpin B11 | Homo sapiens (Human) | PR |
| P01011 | SERPINA3 | Alpha-1-antichymotrypsin | Homo sapiens (Human) | PR |
| P12388 | Serpinb2 | Plasminogen activator inhibitor 2, macrophage | Mus musculus (Mouse) | PR |
| P32261 | Serpinc1 | Antithrombin-III | Mus musculus (Mouse) | PR |
| Q07235 | Serpine2 | Glia-derived nexin | Mus musculus (Mouse) | PR |
| Q5SV42 | Serpinb1c | Leukocyte elastase inhibitor C | Mus musculus (Mouse) | PR |
| Q8BYY9 | Serpina3b | Serine protease inhibitor A3B | Mus musculus (Mouse) | PR |
| Q9D154 | Serpinb1a | Leukocyte elastase inhibitor A | Mus musculus (Mouse) | PR |
| Q9JK88 | Serpini2 | Serpin I2 | Mus musculus (Mouse) | PR |
| Q8CDC0 | Serpinb13 | Serpin B13 | Mus musculus (Mouse) | PR |
| P22777 | Serpine1 | Plasminogen activator inhibitor 1 | Mus musculus (Mouse) | PR |
| Q5I2A0 | Serpina3g | Serine protease inhibitor A3G | Mus musculus (Mouse) | PR |
| P29524 | Serpinb2 | Plasminogen activator inhibitor 2 type A | Rattus norvegicus (Rat) | PR |
| Q6P734 | Serping1 | Plasma protease C1 inhibitor | Rattus norvegicus (Rat) | PR |
| P05545 | Serpina3k | Serine protease inhibitor A3K | Rattus norvegicus (Rat) | PR |
| P07092 | Serpine2 | Glia-derived nexin | Rattus norvegicus (Rat) | PR |
| Q62975 | Serpina10 | Protein Z-dependent protease inhibitor | Rattus norvegicus (Rat) | PR |
| O48706 | At2g26390 | Serpin-Z3 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9M1T7 | At3g45220 | Serpin-Z4 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| Q9ZQR6 | At2g14540 | Serpin-Z2 | Arabidopsis thaliana (Mouse-ear cress) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAGVSPAVFG | CPDVTLGRNT | AVREVQENIT | SVDSLTLASS | NTDFAFSLYK | ELVLKNPDEN |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VVFSPFSICT | ALALLSLGAK | SNTLKEILEG | LKFNLTETPE | PDIHQGFRYL | LDLLSQPGNQ |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VQISTGSALF | IEKHLQILAE | FKEKARALYQ | AEAFTADFQQ | PLEATKLIND | YVSNHTQGKI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KELISDLDKR | TLMVLVNYIY | FKGKWEMPFD | PDDTCKSEFY | LDENRSVKVP | MMKINNLTTP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| YFRDEELSCT | VVELKYTGNA | SAMFILPDQG | KMQQVEASLQ | PETLRNWKDS | LKPRLINELC |
| 310 | 320 | 330 | 340 | 350 | 360 |
| LPKFSISTDY | SLEHILPELG | IRELFSTQAD | LSAITGTKDL | RTSQVVHKAV | LDVAETGTEA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| AAGTGYQNLQ | CCQGVIYSMK | IYFDRPFLMI | ISDTNTHIAL | FMAKVSNPES | DENFLNVEYA |
| 430 | 440 | ||||
| FPQVLEIMPE | YRSVCTCCLP | CLTRQ |